News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Mydecine to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th
Mydecine Innovations Group
Ketamine One Subsidiary KGK Science Contracted To Support A Ketamine Clinical Trial In The United States
Wellbeing Digital Sciences
Universal Ibogaine Commences Trading on the TSX-V
Universal Ibogaine
Universal Ibogaine Announces Enhancement of Board of Directors
Universal Ibogaine
Enveric Biosciences Announces Artificial Intelligence Platform, PsyAI™, Has Identified Viable Drug Candidates from its 'Psybrary' of Psychedelic Molecular Compounds
Enveric Biosciences
Diamond Therapeutics Appoints Renowned Psychiatrist and Author Dr. Torsten Passie to Scientific Advisory Board
Diamond Therapeutics
Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr. Matthew Johnson
Mydecine Innovations Group
Optimi Health Natural Psilocybin Extraction Breakthrough Submitted for Provisional Patent Application
Optimi Health
MindMed Announces Strategic Research Collaboration with Sphere Health
Mind Medicine (MindMed)
Lobe Sciences to Present at the BioFuture 2021 & MoneyShow Virtual Expo Investor Conferences
Lobe Sciences
Origin Therapeutics Portfolio Company TripSitter Expands To Eight Additional States
Origin Therapeutics
Lobe Sciences and the World Boxing Association Announce Initiative Targeting mTBI and PTSD
Lobe Sciences
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.